Phase I Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-986115 in Subjects With Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 12 Sep 2016
At a glance
- Drugs BMS 986115 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb
- 30 Aug 2016 Status changed from completed to discontinued due to non-safety reason, business objectives have changed.
- 29 Aug 2016 Status changed from active, no longer recruiting to completed.
- 25 Jan 2016 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.